Fever of unknown origin due to African trypanosomiasis: A case report

Yıl 2009, Cilt: 14 Sayı: 1, 26 - 28, 14.01.2013

Yann A. Meunier

Öz

Abstract. We report the case of a 28 year old Greek sailor who presented first with a fever of unknown origin and then with the classical symptoms of trypanosomiasis in Ivory Coast, Greece, the USA and France but who was diagnosed late in the evolution of his disease and  suffered incapacitating neurological sequelae despite appropriate treatment. 

Key words: Fever, unknown origin, African trypanosomiasis

Anahtar Kelimeler

Fever, unknown origin, African trypanosomiasis

Kaynakça

• 1. Gentilini M. Trypanososomiases humaines africaines ou maladie du sommeil. In Medecine tropicale, (5th ed.), Paris, Flammarion, 1993, pp 123-134.
• 2. Bourée P. Trypanosomiase africaine. In Aidememoire de parasitologie et de pathologie tropicale, (3rd ed), Paris, SmithKline Beecham, 2001, pp 134-137.
• 3. Comite d’Experts de l’OMS. La trypanosomiase africaine. Epidemiologie et lutte. OMS. Ser Rapp Techn 1986; 739
• 4. Carme B, Jannin J and Eozenou P. La trypanosomiase humaine africaine. Encycl. Med. Chir. (Paris, France). Maladies infectieuses 3-1990, 8095, A10.
• 5. Wellde BT, Chumo DA, Hockmeyer WT et al Sleeping sickness in the Lambwe Valley in 1978. Ann Trop Med Parasitol 1989; 83(Supp 1): 21-27.
• 6. Sinha A, Grace C, Alston WK, et al. African trypanosomiasis in two travelers from the United States. Clin Infect Dis 1999; 29: 840-844.
• 7. OMS/WHO. Trypanosomiase. Situation dans les etats members de l’OCEAC. Releve Epidem. Hebd 1990; 50: 388-391
• 8. Stanghelli A, Roux JF. Techniques de dépistage et de diagnostic de la trypanosomose humaine africaine = Screening and diagnosis techniques of human african trypanosomiasis. Med Trop 1984; 44: 361-367.
• 9. Giordano C, Clerc M, Doutriaux C, et al. Le diagnostic neurologique au cours des differentes phases de la trypanosomiase humaine africaine. Ann Soc Belge Med Trop 1977; 57: 213-225.
• 10. Wery M, Wery-Paskoff S and Van Wetters P. The diagnosis of human African trypanosomiasis (T. gambiense) by the use of fluorescent antibody test. I. Standardization of an easy technique to be used in mass surveys. Ann Soc Belges Med Trop Parasitol Mycol. 1970; 50: 613-34.
• 11. Taelman H., Schechter PJ, Marcelis L, et al. Difluoro-methylornithine, an effective new treatment for Gambian trypanosomiasis. Amer J Med 1987; 82: 607-614.
• 12. Doua F, Boa FY, Schechter PJ, et al. Treatment of human late stage Gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornitine): efficacy and tolerance in 14 cases in Cote d’Ivoire. Am J Trop Med Hyg 1987; 37: 3:525-533.
• 13. Doua F, Miezan TW, Sanon Singaro JR, Boa Yapo F, Baltz T. The efficacy of pentamidine in the treatment of early-stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg 1996; 55: 586-588.
• 14. Ginoux PY, Bissadini N, Frezil JL. Accidents observes lors du traitement de la trypanosomiase au Congo. Med Trop 1984; 44: 351-355.
• 15. Atouguia J, Costa J. Therapy of African trypanosomiasis : current situation. Memorias Instituto Oswaldo Cruz 1999; 94: 221-224.